Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

Authors: Vicky Makker, Drew Rasco, Nicholas J. Vogelzang, Marcia S. Brose, Allen Lee Cohn, James W. Mier, Christopher Di Simone, David M. Hyman, Daniel E. Stepan, Corina E. Dutcus, Emmett V. Schmidt, Matthew Guo, Pallavi Sachdev, Robert Shumaker, Carol Aghajanian, Matthew H. Taylor - The Lancet 2019 cited by 480